Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 8116080)

Published in Tumori on October 31, 1993

Authors

C Rella1, M Coviello, N De Frenza, G Falco, E Chiuri, P Colavito, M Quaranata, A De Leonardis

Author Affiliations

1: Hemostasis and Hematology Laboratory, Oncology Institute, Bari, Italy.

Articles by these authors

Characterization of the murine orthologue of a novel human subtelomeric multigene family. Cytogenet Cell Genet (2001) 0.95

MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res (2007) 0.91

A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat (1996) 0.89

Ovarian bilateral cystic teratomas: diagnosis and therapy in a young woman. Clin Exp Obstet Gynecol (1990) 0.89

Vascular endothelial growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp stem cells. J Biol Regul Homeost Agents (2011) 0.88

[Blood groups of the ABO system and survival rate in gynecologic tumors]. Minerva Ginecol (1995) 0.86

sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis (2007) 0.84

Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer. Thromb Res (1993) 0.83

The role of tumour markers in ovarian cancer. Clin Exp Obstet Gynecol (1990) 0.79

Serum vascular endothelial growth factor concentrations in hepatocellular cancer patients undergoing percutaneously radiofrequency thermal ablation. J Chemother (2004) 0.79

[Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis]. Minerva Ginecol (1993) 0.78

[The choice of the pressor drug in hypotension caused by peridural anesthesia. Observations with methoxamine, metaraminol and mephentermine]. Acta Anaesthesiol (1967) 0.77

Correlation between HPLC-determined lonidamine serum levels and clinical response in patients with advanced ovarian cancer. Anticancer Res (1997) 0.77

Cutaneous vasostomy: technique for treatment of chronic and recurrent epididymitis. Urology (1985) 0.75

[Behavior of heart rate and of arterial pressure during combined dynamic and isometric exercise]. Boll Soc Ital Biol Sper (1976) 0.75

Elimination of pain caused by Small-Carrion prosthesis. Urology (1982) 0.75

[Effects of isometric exercise on the pulmonary circulation in aortic patients]. Boll Soc Ital Biol Sper (1978) 0.75

Chemotherapy and surgery in the treatment of ovarian cancer bulky disease. Tumori (1986) 0.75

[The gestosic syndrome. Treatment programs and results in 138 cases]. Minerva Ginecol (1968) 0.75

[Effects of dynamic and isometric exercise on the respiratory organ]. Boll Soc Ital Biol Sper (1976) 0.75

[Comparative value of the photometric method and gravimetric method for the calculation of intraoperative blood loss in a series of gynecologic and obstetric interventions]. Arch Ostet Ginecol (1967) 0.75

Inactivation of wine spoilage yeasts Dekkera bruxellensis using low electric current treatment (LEC). J Appl Microbiol (2010) 0.75

[Effect of isometric exercise on the lesser circulation in a group of patients with mitral stenosis]. Boll Soc Ital Biol Sper (1978) 0.75

[Effects of isometric exercise on the blood pressure in the small circulation in healthy subjects]. Boll Soc Ital Biol Sper (1978) 0.75

MUC3 and MCA serum levels and steroid receptor content in breast cancer. Int J Biol Markers (2004) 0.75

[A method for veinous catheterization with a plastic catheter in the prevention and therapy of shock in obstetrics and gynecology]. Minerva Anestesiol (1967) 0.75

Vascularised fibula transplant. Technique, early results, indications and limitations. Ital J Orthop Traumatol (1986) 0.75

[Clinical usefulness of CA M26 and CA M29 in breast carcinoma]. J Nucl Med Allied Sci (1991) 0.75

[Method of short-term prophylaxis in the prevention of septic complications after cesarean section]. Minerva Ginecol (1978) 0.75

[Secretory IgA of the cervical mucus in neoplastic and nonneoplastic conditions of the uterine cervix]. Minerva Ginecol (1997) 0.75

Measurement of the ovarian cancer-associated antigen CA 125 in monitoring tumor burden and response to chemotherapy. Tumori (1991) 0.75

[Rheographic evaluation of peripheral blood flow during isometric exercise]. Boll Soc Ital Biol Sper (1980) 0.75

Determination of intraperitoneal mitoxantrone in the serum of cancer patients using a high performance liquid chromatograph coupled to an Advanced Automated Sample Processor (AASP). Biomed Chromatogr (1992) 0.75

[Paget's disease of the vulva. Review and case report]. Minerva Ginecol (1982) 0.75

[Malignant extragenital tumors and pregnancy]. Minerva Ginecol (1967) 0.75

CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma. Int J Cancer Suppl (1988) 0.75

[Effects of isometric exercise (handgrip) on the respiratory system]. Boll Soc Ital Biol Sper (1976) 0.75

[Acute abdomen in the elderly]. Minerva Chir (1990) 0.75

[Sexology and abortion with respect to their psychological and socioeconomic repercussions]. Minerva Ginecol (1976) 0.75

nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma. Int J Oncol (2001) 0.75

Her-2/neu and fibrinolytic factors in human breast-cancer. Int J Oncol (1994) 0.75

[The syndrome of postural hypotension in obstetrics]. Minerva Ginecol (1966) 0.75

Prognostic factors in epithelial ovarian cancer. Eur J Gynaecol Oncol (1992) 0.75

[Nursing in acute alcoholism: approach to problems]. Riv Inferm (1987) 0.75

[Epidemiology of female ano-genital condylomata acuminata. In relation to the presence of specific types of the human papillomavirus]. Minerva Ginecol (1992) 0.75

[Control study of bacterial infections in patients with carcinoma of the breast subjected to radical mastectomy]. Quad Sclavo Diagn (1987) 0.75

[Behavior of circulation time during isometric exercise in a group of patients with acute myocardial infarct]. Boll Soc Ital Biol Sper (1976) 0.75